Edwards Lifesciences
Tracked across 3 events · 20 articles · First seen May 04, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Edwards Lifesciences announced positive 10-year results from its COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its RESILIA tissue, which is expected to positively impact its market position and growth.
May 04, 2026 · 6 articles
Business
Edwards Lifesciences held its annual Asia-Pacific Patient Experience event in Singapore, bringing together patients from Australia, India, Indonesia, South Korea, and Singapore to share their experiences with structural heart disease. The event aimed to foster…
Impact: Edwards Lifesciences organized and hosted the event, reinforcing its patient-focused culture and commitment to innovation in structural heart disease. The event may enhance its reputation and support long-term growth in the Asia Pacific market.
Jul 20, 2026 · 6 articles
Business
Impact: Edwards Lifesciences is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Aug 03, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Edwards Lifesciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard